The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres
Abstract
Treatment of many intracellular infections in the mononuclear phagocytic system (MPS), requires targeting of antibiotics by a drug delivery system. The objective of this study was to examine whether the particular nature of microspheres, made of end-group capped and uncapped poly(lactide) [PLA] and poly(lactide-co-glycolide) [PLGA 50:50 and PLGA 75:25], affect the uptake into and also the activation of monocyte-macrophages. Placebo and gentamicin sulfate containing microspheres were incubated with J774 murine monocyte-macrophages and fresh human blood monocytes. Phagocytosis became more efficient with increasing polymer hydrophobicity, whereas opsonization of the particles in serum exerted inconsistent effects. Monocyte activation was determined by flow cytometry and measured as oxidative burst. The cellular oxidative burst induced by the particles was higher for end-group uncapped polymers. Opsonization increased significantly the oxidative activity of J774 monocytes, but affected inconsistently that of human blood monocytes. The results demonstrate that PLA and PLGA microspheres loaded with gentamicin sulfate were efficiently phagocytosed in vitro. The end-group uncapped polymer-type microspheres promoted significantly cell activation, which may be of importance for drug delivery and targeting to intracellular infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Particle structures smaller than 5 μm are taken up by APCs, such as dendritic cells (DCs) and macrophages [59–61], and are transported directly to the lymph node [58], where the encapsulated antigen can be presented to T cells.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [60]
Citations
Cites
Hansen, M., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,488
Krevelen, D. W. V. (1990) · Cited by 3,264
Silverstein, S. C., Steinman, R. M., & Cohn, Z. A. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003321 · Cited by 1,290
Biodegradable polymers as drug delivery systems
(1992) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(92)90663-b · Cited by 777
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 709
MTT colorimetric assay for testing macrophage cytotoxic activity in vitro
Ferrari, M., Fornasiero, M. C., & Isetta, A. M. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90187-z · Cited by 566
Biodegradable polymers as drug delivery systems
Zhao, L. (1991) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(91)90162-g · Cited by 517
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
Okada, H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00050-1 · Cited by 380
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 368
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B. ‐., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Research works printed but not linked: 1
- Müller, R.H., 1991. Modification of drug carriers. In: Müller, R.H. (Ed.), Colloidal Carriers for Controlled Drug Delivery and Targeting. Wissenschaftliche Verlagsgesellschaft, Stuttgart, CRC Press, Boca Raton, FL, pp. 19–97.
Cited by
Sorted by citations
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delié, F. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,117
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Mirakabad, F. S. T., Nejati‐Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 553
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 468
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
Tamber, H., Johansen, P., Merkle, H. P., & Gander, B. A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.002 · Cited by 318
Self-citationPhysico-chemical features of engineered nanoparticles relevant to their toxicity
Fubini, B., Ghiazza, M., & Fenoglio, I. (2010) · Nanotoxicology · doi:10.3109/17435390.2010.509519 · Cited by 297
Metadata
- Authors
- Prior, S., Gander, B., Blarer, N., Merkle, H. P., Subirá, M. L., Irache, J. M., & Gamazo, C.
- Affiliations
- Universidad de Navarra (ES)
- ETH Zurich (CH)
- Corresponding author
- Gamazo, Carlos
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 15
- Issue
- 2
- Pages
- 197-207
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2057572412
- Cited by
- 138
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 9 · 2015: 5 · 2014: 9 · 2013: 8 · 2012: 6
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- polylactic acid, poly(lactic-co-glycolic acid), microspheres, phagocytosis, monocyte/macrophage activation, polymer hydrophobicity, opsonization, respiratory burst, gentamicin sulfate, intracellular drug delivery, J774 cells, blood monocytes
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Aminoglycosides, Animals, Biocompatible Materials, Cells, Cultured, Gentamicins, Humans, Macrophage Activation, Macrophages, Microspheres, Monocytes, Phagocytosis, Polyesters, Polyglycolic Acid, Polymers, Drug Delivery Systems, Respiratory Burst, Lactic Acid, Mice, Static Electricity, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review